Skip to content
XPR – Lifestyle Demo
Author:
IR DEPARTMENT
Celosia Therapeutics Announces First Patient Dosed in Phase 1b Clinical Trial of CTx1000 in Amyotrophic Lateral Sclerosis
March 23, 2026